new Alzheimer's drug, Reminyl

Janssen will soon market a new Alzheimer's drug, Reminyl. It's a cholinesterase inhibitor derived from daffodil bulbs.

Reminyl will be used as an alternative to Aricept or Exelon.

All of the Alzheimer's drugs can provide similar improvements in cognitive function. The big differences are dosing and side effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote